TUSC8 and breast cancer: Using RT-PCR assay in tumorous and adjacent normal breast tissues in 32 cases of breast cancer patients, we identified that TUSC8 and MYLIP were significantly down-regulated in breast cancer (p < 0.001) (Figure 8A, 8B).